What are the most important barriers for thrombolytic therapy in ischemic stroke patients?

International Journal of Stroke

Volumn 8, Issue 4, 2013, Pages

  Ayromlou, Hormoz ^a   Soleimanpour, Hassan ^b   Farhoudi, Mehdi ^b   Sadeghi Hokmabadi, Elyar ^a   Rajaei Ghafouri, Rouzbeh ^a   Sharifipour, Ehsan ^a   Mostafaei, Somayeh ^a   Najafi Nashali, Mehdi ^b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Emergency Medical Department   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

BLOOD CLOT LYSIS; BLOOD PRESSURE MEASUREMENT; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CAUSE OF DEATH; COMPUTER ASSISTED TOMOGRAPHY; DEVELOPING COUNTRY; DIASTOLIC BLOOD PRESSURE; DRUG CONTRAINDICATION; EMERGENCY CARE; FIBRINOLYTIC THERAPY; FUNCTIONAL NEUROIMAGING; HEART INFARCTION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LABORATORY TEST; LETTER; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PHYSICIAN; PREVALENCE; PRIORITY JOURNAL; SCORING SYSTEM; SEIZURE; STROKE PATIENT; SYSTOLIC BLOOD PRESSURE; THERAPY DELAY;

AGED; BRAIN ISCHEMIA; EARLY DIAGNOSIS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; IRAN; MALE; PLASMINOGEN ACTIVATORS; STROKE; THROMBOLYTIC THERAPY; TOMOGRAPHY, X-RAY COMPUTED; TRANSPORTATION OF PATIENTS;

EID: 84878211507     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/ijs.12093     Document Type: Letter

References (3)

1. Hacke W, Donnan G, Fieschi C, Kaste M, Kummer RV. Association of outcome with early stroke treatment: pooled analysis of ATLANT, ECASS, and NINDS rt-PA stroke trials. Lancet 2004; 363:768-774.
2. Pandiana JD, Padma V, Vijaya P, Sylaja PN, Murthy JMK. Stroke and thrombolysis in developing countries. Int J Stroke 2007; 2:17-26.
3. Hosseini AA, Sobhani-Rad D, Ghandehari K, Benamer HTS. Frequency and clinical patterns of stroke in Iran - systematic and critical review. BMC Neurol 2010; 10:72.